Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ruibal

Showing results (161-170 of 266) with videos related to

Pageof 27
Sort By:
The International Journal of Biological Markers|April 1, 1989
Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative studyJ Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Medicina Clinica|May 14, 1983
[CA 19.9 as tumor marker: preliminary results]A Ruibal, G Encabo, J Fernández Llamazares, et al.
Actas Urologicas Espanolas|March 1, 1987
[Evaluation of the specificity of specificity of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostate pathology]J Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Medicina Clinica|March 24, 1984
[Serum tissue polypeptide antigen in non-oncologic clinic. Study of false positives]A Ruibal, G Encabo, P Durán Bellido, et al.
The International Journal of Biological Markers|July 1, 1990
Serum SLX levels in patients with non tumoral pathologies. Our experience in 189 casesM T Allende, M C Roiz, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1991
High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic diseaseF Vizoso, M T Allende, R Fernàndez, et al.
The International Journal of Biological Markers|January 1, 1991
Seric BCM-RIA levels in patients with lung pathologiesM T Allende, J Hernández, A Bianco, et al.
Arthritis and Rheumatism|January 11, 2003
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid outputF Perez-Ruiz, M Calabozo, G García Erauskin, et al.
The International Journal of Biological Markers|January 1, 1990
Serum BCM levels in patients with non-tumoral pathologies: a value of 25 U/ml can be used as threshold for tumoral activityM T Allende, F Vizoso, A Fueyo, et al.
Bulletin Du Cancer|January 1, 1988
CEA MARIA serum levels in gastrointestinal pathologiesA Ruibal, L Pombo, A Soriano, et al.
Pageof 27

Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
The International Journal of Biological Markers|April 1, 1989
Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative studyJ Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Medicina Clinica|May 14, 1983
[CA 19.9 as tumor marker: preliminary results]A Ruibal, G Encabo, J Fernández Llamazares, et al.
Actas Urologicas Espanolas|March 1, 1987
[Evaluation of the specificity of specificity of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostate pathology]J Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Medicina Clinica|March 24, 1984
[Serum tissue polypeptide antigen in non-oncologic clinic. Study of false positives]A Ruibal, G Encabo, P Durán Bellido, et al.
The International Journal of Biological Markers|July 1, 1990
Serum SLX levels in patients with non tumoral pathologies. Our experience in 189 casesM T Allende, M C Roiz, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1991
High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic diseaseF Vizoso, M T Allende, R Fernàndez, et al.
The International Journal of Biological Markers|January 1, 1991
Seric BCM-RIA levels in patients with lung pathologiesM T Allende, J Hernández, A Bianco, et al.
Arthritis and Rheumatism|January 11, 2003
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid outputF Perez-Ruiz, M Calabozo, G García Erauskin, et al.
The International Journal of Biological Markers|January 1, 1990
Serum BCM levels in patients with non-tumoral pathologies: a value of 25 U/ml can be used as threshold for tumoral activityM T Allende, F Vizoso, A Fueyo, et al.
Bulletin Du Cancer|January 1, 1988
CEA MARIA serum levels in gastrointestinal pathologiesA Ruibal, L Pombo, A Soriano, et al.
Pageof 27